WP1066, a novel small molecule inhibitor of STAT3, exhibits significant antitumor effect in advanced melanoma patients by inhibiting the proliferation of Tregs and enhancing the TCR activation on ZAP-70 [135]. Here, STAT3 is linked to melanoma.